Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305

Clinical trial NCT00915356 · COMPLETED

Trial details

NCT number: NCT00915356
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2009-05-01
Primary completion: 2009-12-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.